TFA
BVS icon

Transamerica Financial Advisors’s Bioventus BVS Stock Holding History

Transamerica Financial Advisors’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18
Closed -$120 – 1844
2025
Q3 		$120 Buy
+18
New +$125 ﹤0.01% 1501

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Transamerica Financial Advisors's BVS Position: Q4 2025 in Review

Transamerica Financial Advisors sold out of Bioventus (BVS) in Q4 2025, closing a stake of 18 shares — an estimated $120 sold.

Transamerica Financial Advisors first reported a position in BVS in Q3 2025 and held it in 1 quarter. The position peaked at $120 in Q3 2025. 148 funds tracked by Wall St. Rank hold BVS as of Q4 2025.

  • Transamerica Financial Advisors reported no remaining Bioventus position as of Q4 2025 after selling out during the quarter.
  • Transamerica Financial Advisors sold 18 Bioventus shares in Q4 2025, an estimated $120.
  • Transamerica Financial Advisors first reported a position in Bioventus in Q3 2025 and held it in 1 quarter.
  • Transamerica Financial Advisors's Bioventus position peaked at $120 in Q3 2025.
  • 148 funds tracked by Wall St. Rank held Bioventus as of Q4 2025.

Based on Transamerica Financial Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.